Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naomi L. Sharma
Observed names:
Naomi L Sharma,
Naomi Laura Sharma,
Naomi Sharma,
Naomi L. Sharma
Observed institutions:
University of Cambridge,
Royal Berkshire Hospital,
Churchill Hospital,
Cancer Research UK,
University of Oxford,
Cancer Research UK Cambridge Center,
CRUK/MRC Oxford Institute for Radiation Oncology,
Oxford University Hospitals NHS Trust,
Addenbrooke's Hospital
show all 9
OpenAlex ID:
A5100893408
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
2011
·
Charles E Massie
, Andy Lynch
, et al.
·
The EMBO Journal
·
624
PDF
The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
2012
·
Naomi L. Sharma
, Charlie E. Massie
, et al.
·
Cancer Cell
·
405
PDF
HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E2F1‐mediated cell cycle network
2014
·
Antonio Ramos‐Montoya
, Alastair D Lamb
, et al.
·
EMBO Molecular Medicine
·
79
First 500 cases of robotic‐assisted laparoscopic radical prostatectomy from a single UK centre: learning curves of two surgeons
2010
·
Naomi Laura Sharma
, Alexandros Papadopoulos
, et al.
·
British Journal of Urology
·
57
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
2014
·
Naomi L. Sharma
, Charlie E. Massie
, et al.
·
Nucleic Acids Research
·
55
PDF
The emerging role of histone deacetylase ( HDAC ) inhibitors in urological cancers
2013
·
Naomi L. Sharma
, Blaz Groselj
, et al.
·
British Journal of Urology
·
38
Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2014
·
Martin Kerr
, Helen E. Scott
, et al.
·
Clinical Cancer Research
·
27
Detailed analysis of operating time learning curves in robotic prostatectomy by a novice surgeon
2011
·
Harveer Dev
, Naomi L. Sharma
, et al.
·
British Journal of Urology
·
25
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre
2016
·
Vincent J. Gnanapragasam
, David Thurtle
, et al.
·
British Journal of Urology
·
15
PDF
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel
2016
·
Benjamin C Thomas
, Jonathan D Kay
, et al.
·
Endocrine Related Cancer
·
14
PDF
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations
2011
·
Lih‐Ming Wong
, Richard Johnston
, et al.
·
British Journal of Urology
·
10
The management of adult urinary incontinence
2017
·
Naomi L. Sharma
, Steve Foley
·
Surgery (Oxford)
·
3
Organ-Confined Prostate Cancer: Are We Moving Towards More or Less Radical Surgical Intervention?
2015
·
Daniel J. Stevens
, Naomi L. Sharma
, et al.
·
Current Urology Reports
·
3
Role of Hes6 in castration-resistant prostate cancer
2014
·
Alastair D Lamb
, Antonio Ramos-Montoya
, et al.
·
The Lancet
·
1
Supplementary Figure S4 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Table S1 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Methods from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Table S1 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Figure S1 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Data from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Methods from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Data from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Figure S2 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Figure S1 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Supplementary Figure S3 from Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer
2023
·
Martin Kerr
, Helen E. Scott
, et al.
Show more works
View as search
Works count:
30
Citation count:
1,356
H-index:
10
I10-index:
11
Year
Topic
Type